Advertisement

defibrillator

Exploring Variances in Dual-Chamber ICD Use

Each year in the United States, approximately 140,000 implantable cardioverter-defibrillators (ICDs) are implanted in cardiac patients. Physicians often face challenges when working with patients to decide whether it’s best to...

Primary Prevention ICDs Yield Survival Benefits

Among eligible patients, those who undergo implantable cardioverter-defibrillator (ICD) implantation appear to benefit from a significantly decreased mortality rate when compared with those who do not undergo implantation,...

Improving Survival After Heart Failure

Heart failure (HF) is among the leading causes of hospitalization in the United States, afflicting more than 5.8 million men and women each year. The disease has been associated with substantial morbidity, mortality, and...

Hypertrophic Cardiomyopathy: A Welcome Guideline Update

Hypertrophic cardiomyopathy (HCM) is one of the most common genetic heart diseases in the United States, affecting approximately 600,000 to 700,000 people. In many cases, patients remain unidentified. This, in part, may explain...

Investigating Referrals for ICDs

The American College of Cardiology, American Heart Association, and Heart Rhythm Society have published guidelines that provide patient selection criteria for the use of implantable cardioverter-defibrillators (ICDs) as primary...

Analyzing Preventive CRT in the Elderly

Published studies have shown that the prevalence of congestive heart failure (CHF) increases as people age, rising from 2% to 3% in the total population to 10% to 20% after patients reach age 75. When compared with younger...

Heart Rhythm 2012

Examining Criteria for ICD Primary Prevention Therapy The Particulars: Studies have suggested that nearly 25% of implantable cardioverter-defibrillators (ICDs) for primary prevention are implanted outside of evidence-based...

Loading

Advertisement

For latest news and updates
Email-id is invalid

Meeting Coverage